Identification of efflux pump-mediated multidrug-resistant bacteria by the ethidium bromide-agar cartwheel method

In Vivo

Volumn 25, Issue 2, 2011, Pages 171-178

  Martins, Marta ^a,b   Viveiros, Miguel ^a,c   Couto, Isabel ^a,d   Costa, Sofia S ^a   Pacheco, Teresa ^e   Fanning, Séamus ^b,c   Pagès, Jean Marie ^c,f   Amaral, Leonard ^a,c  

^a INSTITUTO DE HIGIENE E MEDICINA TROPICAL   (Portugal)

^b UNIVERSITY COLLEGE DUBLIN   (Ireland)

^c COST Action BM0701 ^*  (Portugal)

^d UNIVERSIDADE NOVA DE LISBOA   (Portugal)

^e HOSPITAL EGAS MONIZ   (Portugal)

^f AIX MARSEILLE UNIVERSITY   (France)

Author keywords

Efflux activity; Efflux pumps; Ethidium bromide; Multidrug resistance; Screening method

Indexed keywords

AGAR; ANTIBIOTIC AGENT; CHLORPROMAZINE; ETHIDIUM BROMIDE; NAPHTHALENE DERIVATIVE; PHENYLARGININE BETA NAPHTHYLAMIDE; THIORIDAZINE; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CARTWHEEL METHOD; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENTEROBACTER AEROGENES; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; ESCHERICHIA COLI; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; SALMONELLA ENTERITIDIS; SALMONELLA TYPHIMURIUM; STAPHYLOCOCCUS AUREUS; TECHNIQUE;

EID: 79954994775     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Kumar A and Schweizer HP: Bacterial resistance to antibiotics: active efflux and reduced uptake. Adv Drug Deliv Rev 57: 1486-1513, 2005.
2. Nelson ML: Modulation of antibiotic efflux in bacteria. Curr Med Chem 1: 35-54, 2002.
3. Piddock LJ: Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteria. Clin Microbiol Rev 19: 382-402, 2006.
4. Webber MA and Piddock LJV: The importance of efflux pumps in bacterial antibiotic resistance. J Antimicrob Chemother 51: 9-11, 2003.
5. Zgurskaya HI and Nikaido H: Multidrug resistance mechanisms: drug efflux across two membranes. Mol Microb 37: 219-225, 2000. (Pubitemid 30481007)
6. Nikaido H: The role of outer membrane and efflux pumps in the resistance of Gram-negative bacteria. Can we improve drug access? Drug Resist Updat 1: 93-98, 1998.
7. Tenover FC: Mechanisms of antimicrobial resistance in bacteria. Am J Infect Control 34(5 Suppl 1): S3-S10, 2006.
8. Kern WV, Steinke P, Schumacher A, Schuster S, von Baum H and Bohnert JA: Effect of 1-(1-naphthylmethyl)-piperazine, a novel putative efflux pump inhibitor, on antimicrobial drug susceptibility in clinical isolates of Escherichia coli. J Antimicrob Chemother 57: 339-343, 2006. (Pubitemid 43160180)
9. Raherison S, Gonzalez P, Renaudin H, Charron A, Bébéar C and Bébéar CM: Evidence of active efflux in resistance to ciprofloxacin and to ethidium bromide by Mycoplasma hominis. Antimicrob Agents Chemother 46: 672-679, 2002.
10. Ghisalberti D, Mahamoud A, Chevalier J, Baitiche M, Martino M, Pagès JM and Barbe J: Chloroquinolines block antibiotic efflux pumps in antibiotic-resistant Enterobacter aerogenes isolates. Int J Antimicrob Agents 27: 565-569, 2006. (Pubitemid 43786372)
11. Mahamoud A, Chevalier J, Davin-Regli A, Barbe J and Pagès JM: Quinoline derivatives as promising inhibitors of antibiotic efflux pump in multidrug-resistant Enterobacter aerogenes isolates. Curr Drug Targets 7: 843-847, 2006.
12. Mortimer PG and Piddock LJ: A comparison of methods used for measuring the accumulation of quinolones by Enterobacteriaceae, Pseudomonas aeruginosa and Staphylococcus aureus. J Antimicrob Chemother 28: 639-653, 1991.
13. Martins M, Santos B, Martins A, Viveiros M, Couto I, Cruz A, Pagès JM, Molnar J, Fanning S, Amaral L and Management Committee Members of Cost B16, European Commission/European Science Foundation: An instrument-free method for the demonstration of efflux pump activity of bacteria. In Vivo 20: 657-664, 2006.
14. Viveiros M, Jesus A, Brito M, Leandro C, Martins M, Ordway D, Molnar AM, Molnar J and Amaral L: Inducement and reversal of tetracycline resistance in Escherichia coli K-12 and the expression of proton gradient dependent multidrug efflux pump genes. Antimicrob Agents Chemother 49: 3578-3582, 2005. (Pubitemid 41060625)
15. Viveiros M, Dupont M, Rodrigues L, Couto I, Davin-Regli A, Martins M, Pagès JM and Amaral L: Antibiotic stress, genetic response and altered permeability of Escherichia coli. PLoS ONE 2: e365, 2007.
16. Okuso H, Ma D and Nikaido H: AcrAB efflux pump plays a major role in the antibiotic resistance phenotype of Escherichia coli multiple-antibiotic- resistance (Mar) mutants. J Bacteriol 178: 306-308, 1996. (Pubitemid 26006095)
17. Chevalier J, Mulfinger C, Garnotel E, Nicolas P, Davin-Régli A and Pagès JM: Identification and evolution of drug efflux pump in clinical Enterobacter aerogenes strains isolated in 1995 and 2003. PLoS ONE 3: e3203, 2008.
18. Quinn T, O'Mahony R, Baird AW, Drudy D, Whyte P and Fanning S: Multi-drug resistance in Salmonella enterica: efflux mechanisms and their relationships with the development of chromosomal resistance gene clusters. Curr Drug Targets 7: 849-860, 2006.
19. Couto I, Costa SS, Viveiros M, Martins M and Amaral L: Efflux-mediated response of Staphylococcus aureus exposed to ethidium bromide. J Antimicrob Chemother 62: 504-513, 2008.
20. Sanches IS, Ramirez M, Troni H, Abecassis M, Padua M, Tomasz A and de Lencastre H: Evidence for the geographic spread of a methicillin-resistant Staphylococcus aureus clone between Portugal and Spain. J Clin Microbiol 33: 1243-1246, 1995.
21. Clinical and Laboratory Standards Institute: Performance Standards for Antimicrobial Susceptibility Testing: Fifteenth Informational Supplement M100-S16. CLSI, Wayne, PA, USA, 2006.
22. O'Regan E, Quinn T, Pagès JM, McCusker M, Piddock L and Fanning S: Multiple regulatory pathways associated with high-level ciprofloxacin and multidrug resistance in Salmonella enterica serovar enteritidis: involvement of RamA and other global regulators. Antimicrob Agents Chemother 53: 1080-1087, 2009.
23. Henriques Normark B and Normark S: Antibiotic tolerance in pneumococci. Clin Microbiol Infect 8: 613-622, 2002.
24. Pagès JM, Masi M and Barbe J: Inhibitors of efflux pumps in Gram-negative bacteria. Trends Mol Med 11: 382-389, 2005. (Pubitemid 41080580)
25. Viveiros M, Martins M, Couto I, Rodrigues L, Spengler G, Martins A, Kristiansen JE, Molnar J and Amaral L: New methods for the identification of efflux-mediated MDR bacteria, genetic assessment of regulators and efflux pump constituents, characterization of efflux systems and screening for inhibitors of efflux pumps. Curr Drug Targets 9: 760-778, 2008.